UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000045843 |
|---|---|
| Receipt number | R000052305 |
| Scientific Title | Effect of skin moisturizing in micro bubble bathing |
| Date of disclosure of the study information | 2021/10/23 |
| Last modified on | 2022/04/24 17:21:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of skin moisturizing in micro bubble bathing
Acronym
Effect of skin moisturizing in micro bubble bathing
Scientific Title
Effect of skin moisturizing in micro bubble bathing
Scientific Title:Acronym
Effect of skin moisturizing in micro bubble bathing
Region
| Japan |
Condition
Condition
dry skin
Classification by specialty
| Dermatology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the moisturizing effect of tap water bathing and micro bubble bath bathing on the skin using a micro bubble bath unit.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
stratum corneum water content
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
Micro bubble hand bathing,
single time
Interventions/Control_2
Tap water hand bathing,
single time
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Subjects who have received sufficient explanation about the purpose and contents of this test, have the ability to consent, voluntarily apply for participation after understanding it well, and can consent to participate in this test in writing.
Key exclusion criteria
Serious illness, skin disease on the forearm, special skin care, sunburn beyond daily life within 4 weeks, doctor judged inappropriate.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Yuko |
| Middle name | |
| Last name | Iwama |
Organization
Rinnai Corporation
Division name
R&D Headquarters
Zip code
480-0133
Address
3-1 Kaechi, Oguchi-cho,Niwa-gun, Aichi, Japan
TEL
0587-95-5162
rsiken200214@gmail.com
Public contact
Name of contact person
| 1st name | Yuko |
| Middle name | |
| Last name | Iwama |
Organization
Rinnai Corporation
Division name
R&D Headquarters
Zip code
480-0133
Address
3-1 Kaechi, Oguchi-cho,Niwa-gun, Aichi, Japan
TEL
0587-95-5162
Homepage URL
rsiken200214@gmail.com
Sponsor or person
Institute
Rinnai Corporation
Institute
Department
Personal name
Funding Source
Organization
Rinnai Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Tokyo City University/ Japan Health & Research Institute
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Japan Health & Research Institute
Address
Garou Building 8F 3-1-4 Nihonbashi Cyuou-ku, Tokyo
Tel
03-5290-1621
info@jph-ri.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 10 | Month | 23 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
https://www.jstage.jst.go.jp/article/jjhr/advpub/0/advpub_202243G04/_article/-char/ja
Number of participants that the trial has enrolled
15
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Main results already published
Date of protocol fixation
| 2021 | Year | 10 | Month | 21 | Day |
Date of IRB
| 2021 | Year | 10 | Month | 19 | Day |
Anticipated trial start date
| 2021 | Year | 10 | Month | 25 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 10 | Month | 23 | Day |
Last modified on
| 2022 | Year | 04 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052305
